However, the impaired β cell function observed with T1D serum treatment of human islets was significantly improved in the presence of OPG and DMB, but not with vehicle or IgG treatment (Fig. 9E). The gene discussed is HLA-DMB; the disease is type 1 diabetes mellitus.